Research found just 4% of trials over the past decade allowed the inclusion of pregnant women.

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.

This year's conference in Manchester brought the brightest minds together to discuss bold new ways to treat diagnose and prevent dementia.

Until now, sapphire has been the industry's benchmark for that precision. It is harder than steel, produces clean tissue ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...

The phase 3 SUCCESSOR-2 trial shows mezigdomide-based therapy improves PFS in R/R multiple myeloma patients previously exposed to lenalidomide.

Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained ...

A study led by a speech neuroscientist at The University of Texas at Dallas sheds light on how damage from stroke disrupts the brain mechanisms required for fluent speech. The research, published in ...

DT Research will showcase the DT574 medical-grade All-in-One (AIO) computer and the WebDT Battery Fleet Manager at the HIMSS 2026 Global Health Conference and Exhibition in booth 1964, March 10-12, in ...

Arkansas State University’s Department of Communication Disorders has established an ALLIANCE Lab to assist children with learning difficulties.